The Future of Obesity Drugs Just Got Way More Real
Wegovy is about to go mainstream.
by Yasmin Tayag
Nov 15, 2023
4 minutes
A wild idea recently circulated about the future of aviation: If passengers lose weight via obesity drugs, airlines could potentially cut down on fuel costs. In September, analysts at Jefferies Bank estimated that in the “slimmer society” obesity drugs will create, United Airlines could save up to $80 million in jet fuel annually.
In the past year, as more Americans have learned about semaglutide, which is sold for diabetes under the brand name Ozempic and for obesity under the name Wegovy, hype has become completely divorced from reality. For all the grand predictions, just a fraction of Americans who qualify for obesity drugs are
You’re reading a preview, subscribe to read more.
Start your free 30 days